Literature DB >> 10545267

Components of vectors for gene transfer and expression in mammalian cells.

S C Makrides1.   

Abstract

Progress in diverse scientific fields has been realized partly by the continued refinement of mammalian gene expression vectors. A growing understanding of biological processes now allows the design of vector components to meet specific objectives. Thus, gene expression in a tissue-selective or ubiquitous manner may be accomplished by selecting appropriate promoter/enhancer elements; stabilization of labile mRNAs may be effected through removal of 3' untranslated regions or fusion to heterologous stabilizing sequences; protein targeting to selected tissues or different organelles is carried out using specific signal sequences; fusion moieties effect the detection, enhanced yield, surface expression, prolongation of half-life, and facile purification of recombinant proteins; and careful tailoring of the codon content of heterologous genes enhances protein production from poorly translated transcripts. The use of viral as well as nonviral genetic elements in vectors allows the stable replication of episomal elements without the need for chromosomal integration. The development of baculovirus vectors for both transient and stable gene expression in mammalian cells has expanded the utility of such vectors for a broad range of cell types. Internal ribosome entry sites are now widely used in many applications that require coexpression of different genes. Progress in gene targeting techniques is likely to transform gene expression and amplification in mammalian cells into a considerably less labor-intensive operation. Future progress in the elucidation of eukaryotic protein degradation pathways holds promise for developing methods to minimize proteolysis of specific recombinant proteins in mammalian cells and tissues. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10545267     DOI: 10.1006/prep.1999.1137

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  11 in total

1.  Expression of human proteins at the Southeast Collaboratory for Structural Genomics.

Authors:  Michael R Mayer; Tamara A Dailey; Clay M Baucom; Jill L Supernak; Michael C Grady; Harris E Hawk; Harry A Dailey
Journal:  J Struct Funct Genomics       Date:  2004

2.  EphA2 targeting peptide tethered bioreducible poly(cystamine bisacrylamide-diamino hexane) for the delivery of therapeutic pCMV-RAE-1γ to pancreatic islets.

Authors:  Katherine S Blevins; Ji Hoon Jeong; Mei Ou; Jonathan H Brumbach; Sung Wan Kim
Journal:  J Control Release       Date:  2011-10-28       Impact factor: 9.776

Review 3.  Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA.

Authors:  Juergen Mairhofer; Reingard Grabherr
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

Review 4.  RNA interference and nonviral targeted gene therapy of experimental brain cancer.

Authors:  Ruben J Boado
Journal:  NeuroRx       Date:  2005-01

5.  Optimization of baculovirus transduction on FreeStyle293 cells for the generation of influenza B/Lee/40.

Authors:  Sabine Nakowitsch; C Kittel; W Ernst; A Egorov; R Grabherr
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

6.  Improvement in nuclear entry and transgene expression of baculoviruses by disintegration of microtubules in human hepatocytes.

Authors:  Mirka Salminen; Kari J Airenne; Rita Rinnankoski; Jenni Reimari; Outi Välilehto; Johanna Rinne; Sanna Suikkanen; Sari Kukkonen; Seppo Ylä-Herttuala; Markku S Kulomaa; Maija Vihinen-Ranta
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 7.  Blood-brain barrier transport of non-viral gene and RNAi therapeutics.

Authors:  Ruben J Boado
Journal:  Pharm Res       Date:  2007-06-08       Impact factor: 4.200

Review 8.  Molecular-genetic imaging of cancer.

Authors:  Il Minn; Mitchell E Menezes; Siddik Sarkar; Keerthi Yarlagadda; Swadesh K Das; Luni Emdad; Devanand Sarkar; Paul B Fisher; Martin G Pomper
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

9.  Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells.

Authors:  Chaoting Liu; Brian Dalby; Weixing Chen; Jennifer M Kilzer; Henry C Chiou
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

10.  One-pot bio-synthesis: N-acetyl-D-neuraminic acid production by a powerful engineered whole-cell catalyst.

Authors:  Fei Tao; Yinan Zhang; Cuiqing Ma; Ping Xu
Journal:  Sci Rep       Date:  2011-11-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.